Holen Sie sich die Stockscreener-App
4.24
3.85%
-0.17
Schlusskurs vom Vortag:
$4.41
Offen:
$4.4
24-Stunden-Volumen:
19,347
Relative Volume:
0.13
Marktkapitalisierung:
$236.86M
Einnahmen:
$34.16M
Nettoeinkommen (Verlust:
$-98.43M
KGV:
-1.812
EPS:
-2.34
Netto-Cashflow:
$-119.33M
1W Leistung:
+2.91%
1M Leistung:
-8.62%
6M Leistung:
+0.00%
1J Leistung:
-48.92%
1-Tages-Spanne:
$4.19
$4.49
1-Wochen-Bereich:
$4.03
$4.69
52-Wochen-Spanne:
$2.9448
$9.70
Foghorn Therapeutics Inc Stock (FHTX) Company Profile
Firmenname
Foghorn Therapeutics Inc
Sektor
Branche
Telefon
617-586-3100
Adresse
500 TECHNOLOGY SQUARE, CAMBRIDGE
Vergleichen Sie FHTX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
FHTX
Foghorn Therapeutics Inc
|
4.19 | 249.30M | 34.16M | -98.43M | -119.33M | -2.34 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.33 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
633.37 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.56 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
817.41 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
181.50 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Foghorn Therapeutics Inc Stock (FHTX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-17 | Fortgesetzt | B. Riley Securities | Buy |
| 2025-04-23 | Eingeleitet | Citizens JMP | Mkt Outperform |
| 2025-01-30 | Eingeleitet | B. Riley Securities | Buy |
| 2024-09-03 | Eingeleitet | Jefferies | Buy |
| 2024-08-19 | Eingeleitet | Evercore ISI | Outperform |
| 2023-03-28 | Eingeleitet | BofA Securities | Buy |
| 2023-01-05 | Eingeleitet | BMO Capital Markets | Outperform |
| 2021-11-22 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-11-17 | Eingeleitet | Cowen | Outperform |
| 2020-11-17 | Eingeleitet | Goldman | Buy |
| 2020-11-17 | Eingeleitet | Morgan Stanley | Overweight |
| 2020-11-17 | Eingeleitet | Wedbush | Outperform |
Alle ansehen
Foghorn Therapeutics Inc Aktie (FHTX) Neueste Nachrichten
Is Foghorn Therapeutics Inc. stock safe for conservative investorsBull Run & Free Weekly Watchlist of Top Performers - newser.com
Foghorn Therapeutics to engage investors at oncology conferences - Traders Union
Foghorn Therapeutics Inc. to Participate in Major Healthcare Conferences in November 2025 - Quiver Quantitative
Foghorn Therapeutics (NASDAQ: FHTX) plans three investor events; webcasts for 90 days - Stock Titan
Is Foghorn Therapeutics Inc. stock bottoming outAnalyst Upgrade & Accurate Intraday Trade Tips - newser.com
Applying big data sentiment scoring on Foghorn Therapeutics Inc.Short Setup & Real-Time Market Trend Scan - newser.com
Published on: 2025-11-03 02:03:18 - newser.com
Why Foghorn Therapeutics Inc. stock could outperform in 2025Market Growth Report & Low Volatility Stock Recommendations - newser.com
Will Foghorn Therapeutics Inc. continue its uptrendWeekly Market Outlook & High Accuracy Buy Signal Tips - newser.com
How moving averages guide Foghorn Therapeutics Inc. tradingMarket Growth Report & Weekly Top Gainers Trade List - newser.com
Published on: 2025-11-02 02:35:38 - newser.com
Can trapped investors hope for a rebound in Foghorn Therapeutics Inc.Market Performance Report & Verified Stock Trade Ideas - newser.com
Why Foghorn Therapeutics Inc. is moving todayPortfolio Value Report & Weekly Hot Stock Watchlists - newser.com
Published on: 2025-11-01 05:22:36 - newser.com
What does recent volatility data suggest for Foghorn Therapeutics Inc.Watch List & Free Verified High Yield Trade Plans - newser.com
Foghorn Therapeutics shares progress on three protein degrader programs - BioWorld MedTech
Can swing trading help recover from Foghorn Therapeutics Inc. lossesJuly 2025 Decliners & Community Trade Idea Sharing Platform - newser.com
Has Foghorn Therapeutics Inc. formed a bullish divergencePortfolio Performance Report & Long-Term Growth Portfolio Plans - newser.com
Foghorn Therapeutics advances ARID1B, CBP, EP300 development - Traders Union
Foghorn Therapeutics Announces Key Pipeline Updates - TipRanks
Foghorn Therapeutics Announces Updates for Selective ARID1B, Selective CBP and Selective EP300 Degrader Programs - The Manila Times
Foghorn Therapeutics Updates on Selective Degrader Programs and Virtual Investor Event Announcement - Quiver Quantitative
Foghorn Therapeutics Inc Announces Pipeline Updates for Degrader Programs - TradingView
Foghorn (Nasdaq: FHTX) updates degraders: ARID1B tied to 5% of solid tumors; CBP IND 2026 - Stock Titan
Momentum divergence signals in Foghorn Therapeutics Inc. chartQuarterly Portfolio Report & AI Forecast for Swing Trade Picks - newser.com
How risky is Foghorn Therapeutics Inc. stock nowEarnings Growth Report & Consistent Profit Trading Strategies - newser.com
Volatility clustering patterns for Foghorn Therapeutics Inc.Quarterly Market Review & Long Hold Capital Preservation Plans - newser.com
Finanzdaten der Foghorn Therapeutics Inc-Aktie (FHTX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.66%
0.84%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):